- Q4'24 net sales of $444.1
million, net income of $14.2
million and earnings per diluted share of $0.81
- Q4'24 non-GAAP net income of $23.6
million and non-GAAP earnings per diluted share of
$1.33
- Full year net sales of $1.84
billion, net income of $116.6
million and earnings per diluted share of $6.51
- Full year non-GAAP net income of $133.5
million and non-GAAP earnings per diluted share of
$7.44
- Delivered Q4'24 and full year adjusted EBITDA of $64.8 million and $310.9
million, respectively
- Generated operating cash flow of $204.6
million in 2024; completed two strategic acquisitions; and
returned $82.4 million to
shareholders through dividends and share repurchases
CONSHOHOCKEN, Pa., Feb. 24,
2025 /PRNewswire/ -- Quaker Houghton ("the Company")
(NYSE: KWR), the global leader in industrial process fluids,
announced its fourth quarter and full year 2024 results today.
|
Three Months
Ended
December 31,
|
|
Twelve Months
Ended
December 31,
|
($ in thousands,
except per share data)
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net sales
|
$
444,086
|
|
$
467,109
|
|
$ 1,839,686
|
|
$ 1,953,313
|
Net income attributable
to Quaker Chemical Corporation
|
14,186
|
|
20,198
|
|
116,644
|
|
112,748
|
Net income attributable
to Quaker Chemical Corporation common shareholders –
diluted
|
0.81
|
|
1.12
|
|
6.51
|
|
6.26
|
Non-GAAP net income
*
|
23,570
|
|
31,949
|
|
133,456
|
|
137,643
|
Non-GAAP earnings per
diluted share *
|
1.33
|
|
1.78
|
|
7.44
|
|
7.65
|
Adjusted EBITDA
*
|
64,783
|
|
76,964
|
|
310,918
|
|
320,379
|
* Refer
to the Non-GAAP Measures and Reconciliations section below for
additional information.
|
Fourth Quarter 2024 Consolidated Results
Net sales in the fourth quarter of 2024 were $444.1 million, a decrease of 5% compared to
$467.1 million in the fourth quarter
of 2023. This result was due to a decrease in selling price and
product mix of approximately 4%, an unfavorable impact from foreign
currency translation of 2%, and a decline in organic sales volumes
of approximately 1%, partially offset by 2% increase in sales from
acquisitions. Selling price and product mix declined due to the
impact of index-based customer contracts and mix of products and
services whereas the decline in organic sales volumes reflect a
continuation of soft end market conditions, partially offset by new
business wins in all segments.
The Company reported net income in the fourth quarter of 2024 of
$14.2 million, or $0.81 per diluted share, compared to $20.2 million or $1.12 per diluted share in the fourth quarter of
2023. As described in further detail in the Non-GAAP section below,
excluding non-recurring and non-core items in each period, the
Company's fourth quarter of 2024 non-GAAP net income and earnings
per diluted share were $23.6 million
and $1.33 respectively compared to
$31.9 million and $1.78 respectively in the prior year period. The
Company generated adjusted EBITDA of $64.8
million in the fourth quarter of 2024, a decrease of
approximately 16% compared to $77.0
million in the fourth quarter of 2023, primarily driven by
the decline in sales and operating margins.
Joseph A. Berquist, Chief
Executive Officer and President, commented, "In 2024, Quaker
Houghton improved its profitability and generated strong cash flow,
while managing through a challenging macro environment. New
business wins across all regions, and especially Asia/Pacific, helped mitigate the impact of
lower end market demand, primarily in the Americas and EMEA
segments. Our business model and balance sheet are strong,
and in 2024 we returned approximately $80
million to shareholders through dividends and share
repurchases while also investing for growth. I want to thank
our Quaker Houghton employees for their dedication to our customers
and their committed execution on our strategic initiatives."
"Looking ahead, our priorities are to deliver sustained growth
and share gains by advancing our enterprise strategy, refocusing
the organization around our unique customer intimate model and
effectively allocating capital. We are taking additional
steps to reduce complexity which are expected to deliver run-rate
cost savings of at least $20 million
in 2025. We anticipate these actions will enhance our
operational efficiency, improve our competitiveness, and better
leverage our global scale. Executing on our strategic
initiatives will enable us to begin to unlock Quaker Houghton's
full potential and we expect to deliver revenue, adjusted EBITDA
and earnings growth in 2025."
Fourth Quarter and Full Year 2024 Segment Results
The Company's fourth quarter and full year 2024 operating
performance of each of its three reportable segments: (i) Americas;
(ii) EMEA; and (iii) Asia/Pacific
are further described below.
|
Three Months
Ended
December 31,
|
|
Twelve Months
Ended
December 31,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net Sales
*
|
|
|
|
|
|
|
|
Americas
|
$
208,585
|
|
$
226,564
|
|
$
882,131
|
|
$
977,095
|
EMEA
|
125,877
|
|
135,745
|
|
536,435
|
|
571,347
|
Asia/Pacific
|
109,624
|
|
104,800
|
|
421,120
|
|
404,871
|
Total net
sales
|
$
444,086
|
|
$
467,109
|
|
$ 1,839,686
|
|
$ 1,953,313
|
Segment operating
earnings *
|
|
|
|
|
|
|
|
Americas
|
$
50,930
|
|
$
61,756
|
|
$
243,957
|
|
$
266,036
|
EMEA
|
18,559
|
|
23,735
|
|
99,426
|
|
104,811
|
Asia/Pacific
|
30,705
|
|
31,854
|
|
122,738
|
|
118,458
|
Total segment
operating earnings
|
$
100,194
|
|
$
117,345
|
|
$
466,121
|
|
$
489,305
|
* Refer
to the Segment Measures and Reconciliations section below for
additional information.
|
The following table summarizes the sales variances by reportable
segment and consolidated operations in the fourth quarter of 2024
compared to the fourth quarter of 2023:
|
|
Sales
volumes
|
|
Selling
price &
product mix
|
|
Foreign
currency
|
|
Acquisition
&
other
|
|
Total
|
Americas
|
|
(1) %
|
|
(3) %
|
|
(4) %
|
|
— %
|
|
(8) %
|
EMEA
|
|
(7) %
|
|
(3) %
|
|
— %
|
|
3 %
|
|
(7) %
|
Asia/Pacific
|
|
5 %
|
|
(3) %
|
|
— %
|
|
3 %
|
|
5 %
|
Consolidated
|
|
(1) %
|
|
(4) %
|
|
(2) %
|
|
2 %
|
|
(5) %
|
Net sales in the Americas segment declined in the fourth quarter
of 2024 compared to same quarter in 2023 primarily as a result of a
decline in selling price and product mix, an unfavorable impact of
foreign currency translation and a modest decline in sales
volumes. Net sales in the EMEA segment declined in the fourth
quarter of 2024 compared to same quarter in 2023 due to a decline
in organic sales volumes and a decline in selling price and product
mix, partially offset by the contribution from the acquisition of
I.K.V. Tribologie IKVT ("IKV"). Net sales in the Asia/Pacific segment increased in the fourth
quarter of 2024 compared to same quarter in 2023 due to an increase
in sales volumes and a contribution from the acquisition of the
Sutai Group ("Sutai"), partially offset by a decline in selling
price and product mix.
The decline in selling price and product mix in the fourth
quarter of 2024 compared to the prior year period reflects the
impact of our index-based customer contracts as well as mix of
products and services. Sales volumes increased in the Asia/Pacific segment primarily due to
continued new business wins and a modest improvement in demand.
Volumes declined in the Americas and EMEA segments in the fourth
quarter of 2024 compared to the prior year period primarily due to
weaker end market conditions, partially offset by new business
wins.
Compared to the third quarter of 2024, total company sales
decreased approximately 4% due to a decline in selling price and
product mix of 2%, a decline in sales volumes of 1% and an
unfavorable impact of foreign currency translation of 1%. Net
sales, sales volumes and selling price and product mix all declined
in the Americas and EMEA segments, due to normal seasonal trends
and a further softening of market conditions, but increased in the
Asia/Pacific segment. All segments
had an unfavorable impact from foreign currency translation in the
fourth quarter compared to the third quarter of 2024.
Operating earnings and operating margins declined in all three
segments in the fourth quarter of 2024 compared to the prior year
period. For the full year 2024, operating earnings increased in the
Asia/Pacific segment and declined
in Americas and EMEA segments compared to the prior year. Operating
margins increased in Americas and EMEA segments and declined
slightly in the Asia/Pacific
segment in the full year 2024 compared to the prior year.
Cash Flow and Liquidity Highlights
Net cash provided by operating activities was $204.6 million for the year ended December 31, 2024, compared to net cash provided
by operating activities of $279.0
million for the year ended December
31, 2023. The higher operating cash flow in the prior year
was primarily a result of a higher inflow of working capital as the
company reduced its inventory levels.
As of December 31, 2024, the
Company's total gross debt was $708.3
million and its cash and cash equivalents was $188.9 million, which resulted in net debt of
$519.4 million. The Company's net
debt divided by its trailing twelve months adjusted EBITDA was
approximately 1.7x. In the fourth quarter of 2024, the Company
repurchased 174,909 shares for approximately $26.3 million. In the full year of 2024, the
Company repurchased 312,997 shares for approximately $49.2 million. In 2024, the Company returned
approximately $82.4 million to
shareholders through dividends and share repurchases.
Non-GAAP Measures and Reconciliations
The information in this press release includes non-GAAP
(unaudited) financial information that includes EBITDA, adjusted
EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP
operating margin, non-GAAP net income and non-GAAP earnings per
diluted share. The Company believes these non-GAAP financial
measures provide meaningful supplemental information as they
enhance a reader's understanding of the financial performance of
the Company, facilitate a comparison among fiscal periods, and
exclude items that management believes are not indicative of future
operating performance or core to the Company's operations. Non-GAAP
results are presented for supplemental informational purposes only
and should not be considered a substitute for the financial
information presented in accordance with GAAP. In addition, our
definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin,
non-GAAP operating income, non-GAAP operating margin, non-GAAP net
income, and non-GAAP earnings per share, as discussed and
reconciled below to the most comparable GAAP measures, may not be
comparable to similarly named measures reported by other
companies.
The Company presents EBITDA which is calculated as net income
attributable to the Company before depreciation and amortization,
interest expense, net, and taxes on income before equity in net
income of associated companies. The Company also presents adjusted
EBITDA, which is calculated as EBITDA plus or minus certain items
that management believes are not indicative of future operating
performance or not considered core to the Company's operations. In
addition, the Company presents non-GAAP operating income which is
calculated as operating income plus or minus certain items that
management believes are not indicative of future operating
performance or considers core to the Company's operations. Adjusted
EBITDA margin and non-GAAP operating margin are calculated as the
percentage of adjusted EBITDA and non-GAAP operating income to
consolidated net sales, respectively. The Company believes these
non-GAAP measures provide transparent and useful information and
are widely used by analysts, investors, and competitors in our
industry as well as by management in assessing the operating
performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and
non-GAAP earnings per diluted share as additional performance
measures. Non-GAAP net income is calculated as adjusted EBITDA,
defined above, less depreciation and amortization, interest
expense, net, and taxes on income before equity in net income of
associated companies, in each case adjusted, as applicable, for any
depreciation, amortization, interest or tax impacts resulting from
the non-core items identified in the reconciliation of net income
attributable to the Company to adjusted EBITDA. Non-GAAP earnings
per diluted share is calculated as non-GAAP net income per diluted
share as accounted for under the "two-class share method." The
Company believes that non-GAAP net income and non-GAAP earnings per
diluted share provide transparent and useful information and are
widely used by analysts, investors, and competitors in our industry
as well as by management in assessing the performance of the
Company on a consistent basis.
As it relates to future projections for the Company as well as
other forward-looking information contained in this press release,
the Company has not provided guidance for comparable GAAP measures
or a quantitative reconciliation of forward-looking non-GAAP
financial measures to the most directly comparable U.S. GAAP
measure because it is unable to determine with reasonable certainty
the ultimate outcome of certain significant items necessary to
calculate such measures without unreasonable effort. These items
include, but are not limited to, certain non-recurring or non-core
items the Company may record that could materially impact net
income. These items are uncertain, depend on various factors, and
could have a material impact on the U.S. GAAP reported results for
the guidance period.
The Company's reference to trailing twelve months adjusted
EBITDA within this press release refers to the twelve month period
ended December 31, 2024 adjusted
EBITDA of $310.9 million, as
presented in the non-GAAP reconciliations below.
Certain of the prior period non-GAAP financial measures
presented in the following tables have been adjusted to conform
with current period presentation. The following tables reconcile
the Company's non-GAAP financial measures (unaudited) to their most
directly comparable GAAP (unaudited) financial measures (dollars in
thousands unless otherwise noted, except per share amounts):
|
Three Months
Ended
December 31,
|
Twelve Months
Ended
December 31,
|
Non-GAAP Operating
Income and Margin Reconciliations:
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Operating
income
|
$
29,013
|
|
$
48,253
|
|
$ 194,706
|
|
$ 214,495
|
Acquisition-related
expenses
|
956
|
|
—
|
|
1,854
|
|
—
|
Restructuring and
related charges, net
|
1,743
|
|
1,554
|
|
6,530
|
|
7,588
|
Strategic planning
expenses (credits)
|
—
|
|
945
|
|
(290)
|
|
4,704
|
Executive transition
costs
|
6,556
|
|
—
|
|
7,288
|
|
688
|
Customer insolvency
costs
|
1,691
|
|
—
|
|
3,213
|
|
—
|
Other
charges
|
494
|
|
132
|
|
399
|
|
299
|
Non-GAAP operating
income
|
$
40,453
|
|
$
50,884
|
|
$ 213,700
|
|
$ 227,774
|
Non-GAAP operating
margin (%)
|
9.1 %
|
|
10.9 %
|
|
11.6 %
|
|
11.7 %
|
EBITDA, Adjusted
EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income
Reconciliations:
|
Three Months
Ended
December 31,
|
Twelve Months
Ended
December 31,
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net income attributable
to Quaker Chemical Corporation
|
$
14,186
|
|
$
20,198
|
|
$ 116,644
|
|
$ 112,748
|
Depreciation and
amortization (a)
|
21,201
|
|
20,809
|
|
85,108
|
|
83,020
|
Interest expense,
net
|
9,077
|
|
11,955
|
|
41,002
|
|
50,699
|
Taxes on income before
equity in net income of associated companies (b)
|
8,847
|
|
18,629
|
|
49,300
|
|
55,585
|
EBITDA
|
53,311
|
|
71,591
|
|
292,054
|
|
302,052
|
Equity income in a
captive insurance company
|
(1,664)
|
|
(1,342)
|
|
(2,930)
|
|
(2,090)
|
Acquisition-related
expenses (credits)
|
956
|
|
—
|
|
1,454
|
|
(475)
|
Restructuring and
related charges, net
|
1,743
|
|
1,554
|
|
6,530
|
|
7,588
|
Strategic planning
expenses (credits)
|
—
|
|
945
|
|
(290)
|
|
4,704
|
Executive transition
costs
|
6,556
|
|
—
|
|
7,288
|
|
688
|
Customer insolvency
costs
|
1,691
|
|
—
|
|
3,213
|
|
—
|
Facility remediation
recoveries, net
|
—
|
|
(1,127)
|
|
—
|
|
(2,141)
|
Product liability
claim costs, net
|
1,144
|
|
—
|
|
2,040
|
|
—
|
Business interruption
insurance proceeds
|
—
|
|
—
|
|
(1,000)
|
|
—
|
Currency conversion
impacts of hyper-inflationary economies
|
478
|
|
4,980
|
|
811
|
|
7,849
|
Other
charges
|
568
|
|
363
|
|
1,748
|
|
2,204
|
Adjusted
EBITDA
|
$
64,783
|
|
$
76,964
|
|
$ 310,918
|
|
$ 320,379
|
Adjusted EBITDA margin
(%)
|
14.6 %
|
|
16.5 %
|
|
16.9 %
|
|
16.4 %
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
$
64,783
|
|
$
76,964
|
|
$ 310,918
|
|
$ 320,379
|
Less: Depreciation and
amortization – adjusted (a)
|
21,201
|
|
20,809
|
|
85,108
|
|
83,020
|
Less: Interest
expense, net
|
9,077
|
|
11,955
|
|
41,002
|
|
50,699
|
Less: Taxes on income
before equity in net income of associated companies – adjusted
(b)
|
10,935
|
|
12,251
|
|
51,352
|
|
49,017
|
Non-GAAP net
income
|
$
23,570
|
|
$
31,949
|
|
$ 133,456
|
|
$ 137,643
|
|
Three Months
Ended
December 31,
|
Twelve Months
Ended
December 31,
|
Non-GAAP Earnings
per Diluted Share Reconciliations:
|
2024
|
|
2023
|
|
2024
|
|
2023
|
GAAP earnings per
diluted share attributable to Quaker Chemical
Corporation common shareholders
|
$
0.81
|
|
$
1.12
|
|
$
6.51
|
|
$
6.26
|
Equity income in a
captive insurance company per diluted share
|
(0.09)
|
|
(0.08)
|
|
(0.16)
|
|
(0.12)
|
Acquisition-related
expenses (credits)
|
0.04
|
|
—
|
|
0.06
|
|
(0.03)
|
Restructuring and
related charges, net per diluted share
|
0.08
|
|
0.07
|
|
0.28
|
|
0.32
|
Strategic planning
expenses (credits) per diluted share
|
—
|
|
0.04
|
|
(0.01)
|
|
0.21
|
Executive transition
costs per diluted share
|
0.28
|
|
—
|
|
0.31
|
|
0.03
|
Customer insolvency
costs per diluted share
|
0.07
|
|
—
|
|
0.13
|
|
—
|
Facility remediation
recoveries, net per diluted share
|
—
|
|
(0.04)
|
|
—
|
|
(0.09)
|
Product liability
claim costs, net per diluted share
|
0.05
|
|
—
|
|
0.09
|
|
—
|
Business interruption
insurance proceeds per diluted share
|
—
|
|
—
|
|
(0.04)
|
|
—
|
Currency conversion
impacts of hyper-inflationary economies per diluted
share
|
0.03
|
|
0.28
|
|
0.05
|
|
0.44
|
Other charges per
diluted share
|
—
|
|
0.01
|
|
0.05
|
|
0.09
|
Impact of certain
discrete tax items per diluted share (c)
|
0.06
|
|
0.38
|
|
0.17
|
|
0.54
|
Non-GAAP earnings per
diluted share
|
$
1.33
|
|
$
1.78
|
|
$
7.44
|
|
$
7.65
|
(a)
|
Depreciation and
amortization for the years ended December 31, 2024 and 2023 each
includes $1.0 million of amortization expense recorded within
equity in net income of associated companies in the Company's
Consolidated Statements of Operations, which is attributable to the
amortization of the fair value step up for the Company's 50%
interest in a joint venture in Korea as a result of required
purchase accounting.
|
(b)
|
Taxes on income before
equity in net income of associated companies – adjusted includes
the Company's tax expense adjusted for the impact of any current
and deferred income tax expense (benefit), as applicable, of the
reconciling items presented in the reconciliation of Net income
attributable to Quaker Chemical Corporation to adjusted EBITDA,
above, determined utilizing the applicable rates in the taxing
jurisdictions in which these adjustments occurred, subject to
deductibility. This caption also includes the impact of specific
tax charges and benefits for the year ended December 31, 2024 and
2023.
|
(c)
|
The impacts of certain
discrete tax items include certain impacts of tax law changes,
valuation allowance adjustments, uncertain tax positions, provision
to return and other adjustments, and the impact on certain
intercompany asset transfers. For the year ended December 31, 2023,
the impacts also included $6.7 million of withholding taxes for the
repatriation of non-U.S. earnings.
|
Segment Measures and Reconciliations
Segment operating earnings for each of the Company's reportable
segments are comprised of the segment's net sales less directly
related product costs and other operating expenses. Operating
expenses not directly attributable to the net sales of each
respective segment, such as certain corporate and administrative
costs and restructuring charges, are not included in segment
operating earnings. Other items not specifically identified with
the Company's reportable segments include Interest expense, net and
Other (expense) income, net.
The following table presents information about the performance
of the Company's reportable segments (dollars in thousands):
|
Three Months
Ended
December 31,
|
|
Twelve Months
Ended
December 31,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net
Sales
|
|
|
|
|
|
|
|
Americas
|
$
208,585
|
|
$
226,564
|
|
$
882,131
|
|
$
977,095
|
EMEA
|
125,877
|
|
135,745
|
|
536,435
|
|
571,347
|
Asia/Pacific
|
109,624
|
|
104,800
|
|
421,120
|
|
404,871
|
Total net
sales
|
$
444,086
|
|
$
467,109
|
|
$ 1,839,686
|
|
$ 1,953,313
|
Segment operating
earnings
|
|
|
|
|
|
|
|
Americas
|
$
50,930
|
|
$
61,756
|
|
$
243,957
|
|
$
266,036
|
EMEA
|
18,559
|
|
23,735
|
|
99,426
|
|
104,811
|
Asia/Pacific
|
30,705
|
|
31,854
|
|
122,738
|
|
118,458
|
Total segment
operating earnings
|
100,194
|
|
117,345
|
|
466,121
|
|
489,305
|
Restructuring and
related charges, net
|
(1,743)
|
|
(1,554)
|
|
(6,530)
|
|
(7,588)
|
Non-operating and
administrative expenses
|
(54,418)
|
|
(52,397)
|
|
(203,956)
|
|
(206,398)
|
Depreciation of
corporate assets and amortization
|
(15,020)
|
|
(15,141)
|
|
(60,929)
|
|
(60,824)
|
Operating
income
|
29,013
|
|
48,253
|
|
194,706
|
|
214,495
|
Other (expense) income,
net
|
(931)
|
|
(2,114)
|
|
1,354
|
|
(10,672)
|
Interest expense,
net
|
(9,077)
|
|
(11,955)
|
|
(41,002)
|
|
(50,699)
|
Income before taxes
and equity in net income of associated companies
|
$
19,005
|
|
$
34,184
|
|
$
155,058
|
|
$
153,124
|
Forward-Looking Statements
This press release contains "forward-looking statements" that
fall under the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995 and the Securities Act of 1933, as
amended. These statements can be identified by the fact that they
do not relate strictly to historical or current facts. We have
based these forward-looking statements on assumptions, projections
and expectations about future events that we believe are reasonable
based on currently available information, including statements
regarding the potential effects of economic downturns; tariffs,
including uncertainty surrounding changes in tariffs; inflation and
global supply chain constraints on the Company's business, results
of operations, and financial condition; our expectation that we
will maintain sufficient liquidity and remain in compliance with
the terms of the Company's credit facility; expectations about
future demand and raw material costs; and statements regarding the
impact of increased raw material costs and pricing initiatives.
These forward-looking statements include statements with respect to
our beliefs, plans, objectives, goals, expectations, anticipations,
intentions, financial condition, results of operations, future
performance, and business, which may differ materially from our
actual results, including but not limited to the potential benefits
of acquisitions and divestitures, the impacts on our business as a
result of global supply chain constraints, and our current and
future results and plans and statements that include the words
"may," "could," "should," "would," "believe," "expect,"
"anticipate," "estimate," "intend," "outlook, "target", "possible",
"potential", "plan" or similar expressions. Such statements include
information relating to current and future business activities,
operational matters, capital spending, and financing sources. A
major risk is that demand for the Company's products and services
is largely derived from the demand for its customers' products,
which subjects the Company to uncertainties related to downturns in
a customer's business and unanticipated customer production
slowdowns and shutdowns. Other major risks and uncertainties
include, but are not limited to inflationary pressures, including
increases in raw material costs; supply chain constraints and the
impacts of economic downturns; customer financial instability; high
interest rates and their impact on our and our customers' business
operations; the impacts from acts of war, terrorism and military
conflicts, including those in Ukraine and the Middle East as well as economic, political and
governmental actions taken by various governments and governmental
organizations in response; economic and political disruptions
particularly in light of numerous elections globally and the
possibility of regime changes; the possibility of economic
recession; legislative and regulatory developments including
changes to existing laws and regulations, or the way they are
interpreted, applied or enforced; tariffs, trade restrictions, and
the economic and other sanctions imposed by other nations on
Russia and Belarus and/or other government organizations;
suspensions of activities in Russia by many multinational companies;
foreign currency fluctuations; significant changes in applicable
tax rates and regulations; future terrorist attacks and other acts
of violence; the impacts of consolidation in our industry,
including loss or consolidation of a major customer, the effects of
climate change, fires, or other natural disasters; and the
potential occurrence of cyber-security breaches, cyber-security
attacks and other technology outages and security incidents.
Furthermore, the Company is subject to the same business cycles as
those experienced by our customers in the steel, automobile,
aircraft, industrial equipment, aluminum and durable goods
industries. Our forward-looking statements are subject to risks,
uncertainties and assumptions about the Company and its operations
that are subject to change based on various important factors, some
of which are beyond our control. These risks, uncertainties, and
possible inaccurate assumptions relevant to our business could
cause our actual results to differ materially from expected and
historical results. All forward-looking statements included in this
press release, including expectations about business conditions
during 2024 and future periods, are based upon information
available to the Company as of the date of this press release,
which may change. Therefore, we caution you not to place undue
reliance on our forward-looking statements. For more information
regarding these risks and uncertainties as well as certain
additional risks that we face, refer to the Risk Factors section,
which appears in Item 1A of our Annual Report on Form 10-K for the
year ended December 31, 2024, and in subsequent reports filed
from time to time with the Securities and Exchange Commission. We
do not intend to, and we disclaim any duty or obligation to, update
or revise any forward-looking statements to reflect new information
or future events or for any other reason. This discussion is
provided as permitted by the Private Securities Litigation Reform
Act of 1995.
Conference Call
As previously announced, the Company's investor conference call
to discuss its fourth quarter and full year 2024 performance
is scheduled for Tuesday, February 25,
2025 at 8:30 a.m. ET. A live
webcast of the conference call, together with supplemental
information, can be accessed through the Company's Investor
Relations website at investors.quakerhoughton.com. You can also
access the conference call by dialing 877-269-7756.
About Quaker Houghton
Quaker Houghton is the global leader in industrial process
fluids. With a presence around the world, including operations in
over 25 countries, our customers include thousands of the world's
most advanced and specialized steel, aluminum, automotive,
aerospace, offshore, can, mining, and metalworking companies. Our
high-performing, innovative and sustainable solutions are backed by
best-in-class technology, deep process knowledge and customized
services. With approximately 4,400 employees, including chemists,
engineers and industry experts, we partner with our customers to
improve their operations so they can run even more efficiently,
even more effectively, whatever comes next. Quaker Houghton is
headquartered in Conshohocken,
Pennsylvania, located near Philadelphia in the
United States. Visit quakerhoughton.com to learn more.
QUAKER CHEMICAL
CORPORATION CONSOLIDATED STATEMENTS OF
OPERATIONS (Unaudited; Dollars in thousands,
except per share data)
|
|
Three Months
Ended
December 31,
|
Twelve Months
Ended
December 31,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
Net sales
|
$
444,086
|
|
$
467,109
|
|
$ 1,839,686
|
|
$ 1,953,313
|
Cost of goods
sold
|
287,886
|
|
295,953
|
|
1,153,656
|
|
1,247,669
|
Gross
profit
|
156,200
|
|
171,156
|
|
686,030
|
|
705,644
|
Selling, general and
administrative expenses
|
125,444
|
|
121,349
|
|
484,794
|
|
483,561
|
Restructuring and
related charges, net
|
1,743
|
|
1,554
|
|
6,530
|
|
7,588
|
Operating
income
|
29,013
|
|
48,253
|
|
194,706
|
|
214,495
|
Other (expense) income,
net
|
(931)
|
|
(2,114)
|
|
1,354
|
|
(10,672)
|
Interest expense,
net
|
(9,077)
|
|
(11,955)
|
|
(41,002)
|
|
(50,699)
|
Income before taxes
and equity in net income of associated companies
|
19,005
|
|
34,184
|
|
155,058
|
|
153,124
|
Taxes on income before
equity in net income of associated companies
|
8,847
|
|
18,629
|
|
49,300
|
|
55,585
|
Income before equity
in net income of associated companies
|
10,158
|
|
15,555
|
|
105,758
|
|
97,539
|
Equity in net income of
associated companies
|
4,031
|
|
4,673
|
|
10,971
|
|
15,333
|
Net income
|
14,189
|
|
20,228
|
|
116,729
|
|
112,872
|
Less: Net income
attributable to noncontrolling interest
|
3
|
|
30
|
|
85
|
|
124
|
Net income
attributable to Quaker Chemical Corporation
|
$
14,186
|
|
$
20,198
|
|
$
116,644
|
|
$
112,748
|
|
|
|
|
|
|
|
|
Per share
data:
|
|
|
|
|
|
|
|
Net income attributable
to Quaker Chemical Corporation common shareholders –
basic
|
$
0.80
|
|
$
1.12
|
|
$
6.51
|
|
$
6.27
|
Net income attributable
to Quaker Chemical Corporation common shareholders –
diluted
|
$
0.81
|
|
$
1.12
|
|
$
6.51
|
|
$
6.26
|
Basic weighted average
common shares outstanding
|
17,735,186
|
|
17,901,225
|
|
17,850,462
|
|
17,892,461
|
Diluted weighted
average common shares outstanding
|
17,765,771
|
|
17,921,070
|
|
17,870,067
|
|
17,914,809
|
QUAKER CHEMICAL
CORPORATION
CONSOLIDATED BALANCE
SHEETS
(Unaudited;
Dollars in thousands, except par value)
|
|
December
31,
|
|
2024
|
|
2023
|
ASSETS
|
|
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
188,880
|
|
$
194,527
|
Accounts receivable,
net
|
400,126
|
|
444,950
|
Inventories
|
227,472
|
|
233,857
|
Prepaid expenses and
other current assets
|
59,939
|
|
54,555
|
Total current
assets
|
876,417
|
|
927,889
|
|
|
|
|
Property, plant and
equipment, net
|
229,532
|
|
207,811
|
Right-of-use lease
assets
|
34,120
|
|
38,614
|
Goodwill
|
518,894
|
|
512,518
|
Other intangible
assets, net
|
827,098
|
|
896,721
|
Investments in
associated companies
|
98,012
|
|
101,151
|
Deferred tax
assets
|
9,216
|
|
10,737
|
Other non-current
assets
|
17,360
|
|
18,770
|
Total
assets
|
$ 2,610,649
|
|
$ 2,714,211
|
|
|
|
|
LIABILITIES AND
EQUITY
|
|
|
|
Current
liabilities
|
|
|
|
Short-term borrowings
and current portion of long-term debt
|
$
37,554
|
|
$
23,444
|
Accounts
payable
|
198,137
|
|
184,813
|
Dividends
payable
|
8,572
|
|
8,186
|
Accrued
compensation
|
50,212
|
|
55,194
|
Accrued
restructuring
|
2,297
|
|
3,350
|
Accrued pension and
postretirement benefits
|
2,328
|
|
2,208
|
Other accrued
liabilities
|
80,668
|
|
90,315
|
Total current
liabilities
|
379,768
|
|
367,510
|
|
|
|
|
Long-term
debt
|
669,614
|
|
730,623
|
Long-term lease
liabilities
|
20,028
|
|
22,937
|
Deferred tax
liabilities
|
138,828
|
|
146,957
|
Non-current accrued
pension and postretirement benefits
|
23,783
|
|
29,457
|
Other non-current
liabilities
|
24,445
|
|
31,805
|
Total
liabilities
|
1,256,466
|
|
1,329,289
|
|
|
|
|
Equity
|
|
|
|
Common stock, $1 par
value; authorized 30,000,000 shares; issued and outstanding 2024
–
17,673,607 shares; 2023 – 17,991,988 shares
|
17,674
|
|
17,992
|
Capital in excess of
par value
|
903,781
|
|
940,101
|
Retained
earnings
|
633,731
|
|
550,641
|
Accumulated other
comprehensive loss
|
(201,619)
|
|
(124,415)
|
Total Quaker
shareholders' equity
|
1,353,567
|
|
1,384,319
|
Noncontrolling
interest
|
616
|
|
603
|
Total
equity
|
1,354,183
|
|
1,384,922
|
Total liabilities and
equity
|
$ 2,610,649
|
|
$ 2,714,211
|
QUAKER CHEMICAL
CORPORATION
CONSOLIDATED
STATEMENTS OF CASH FLOWS
(Unaudited;
Dollars in thousands)
|
|
Year Ended December
31,
|
|
2024
|
|
2023
|
Cash flows from
operating activities
|
|
|
|
Net income
|
$
116,729
|
|
$
112,872
|
Adjustments to
reconcile net income to net cash provided by operating
activities:
|
|
|
|
Amortization of debt
issuance costs
|
1,413
|
|
1,413
|
Depreciation and
amortization
|
84,119
|
|
81,987
|
Equity in
undistributed earnings of associated companies, net of
dividends
|
(2,733)
|
|
(11,149)
|
Deferred income
taxes
|
(10,033)
|
|
(11,442)
|
Uncertain tax
positions (non-deferred portion)
|
(2,372)
|
|
(644)
|
Deferred compensation
and other, net
|
4,867
|
|
5,711
|
Share-based
compensation
|
14,991
|
|
14,605
|
Gain on disposal of
property, plant, equipment and other assets
|
(810)
|
|
(1,307)
|
Restructuring and
related charges
|
6,530
|
|
7,588
|
Pension and other
postretirement benefits
|
(4,460)
|
|
(2,079)
|
Increase (decrease) in
cash from changes in current assets and current liabilities, net of
acquisitions:
|
|
|
|
Accounts
receivable
|
24,975
|
|
32,169
|
Inventories
|
(3,244)
|
|
49,751
|
Prepaid expenses and
other current assets
|
(6,242)
|
|
(21)
|
Accrued
restructuring
|
(7,595)
|
|
(9,786)
|
Accounts payable and
accrued liabilities
|
(8,637)
|
|
5,937
|
Estimated taxes on
income
|
(2,920)
|
|
3,415
|
Net cash provided by
operating activities
|
204,578
|
|
279,020
|
Cash flows from
investing activities
|
|
|
|
Investments in
property, plant and equipment
|
(41,794)
|
|
(38,800)
|
Payments related to
acquisitions, net of cash acquired
|
(39,302)
|
|
—
|
Proceeds from
disposition of assets
|
4,676
|
|
11,179
|
Net cash used in
investing activities
|
(76,420)
|
|
(27,621)
|
Cash flows from
financing activities
|
|
|
|
Payments of long-term
debt
|
(57,221)
|
|
(38,932)
|
Borrowings (payments)
on revolving credit facilities, net
|
17,916
|
|
(164,769)
|
Borrowings (payments)
on other debt, net
|
1,441
|
|
(506)
|
Dividends
paid
|
(33,170)
|
|
(31,650)
|
Shares purchased under
share repurchase program
|
(49,247)
|
|
—
|
Other stock related
activity
|
(2,383)
|
|
(2,749)
|
Net cash (used in)
provided by financing activities
|
(122,664)
|
|
(238,606)
|
Effect of foreign
exchange rate changes on cash
|
(11,141)
|
|
771
|
Net (decrease) increase
in cash and cash equivalents
|
(5,647)
|
|
13,564
|
Cash and cash
equivalents at the beginning of the period
|
194,527
|
|
180,963
|
Cash and cash
equivalents at the end of the period
|
$
188,880
|
|
$
194,527
|

View original content to download
multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-fourth-quarter-and-full-year-2024-results-302383754.html
SOURCE Quaker Chemical Corporation